Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer

J Thorac Oncol. 2007 May;2(5 Suppl):S12-4. doi: 10.1097/01.JTO.0000268634.17956.5e.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor*
  • Drug Resistance, Neoplasm / genetics*
  • ErbB Receptors / antagonists & inhibitors*
  • Forecasting
  • Genes, erbB-1
  • Genes, erbB-2
  • Genes, ras
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • ErbB Receptors